These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19117139)

  • 1. X-ray crystallography of agonist/antagonist-bound receptors.
    Pike AC
    Methods Mol Biol; 2009; 505():51-66. PubMed ID: 19117139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphan nuclear receptors adopted by crystallography.
    Ingraham HA; Redinbo MR
    Curr Opin Struct Biol; 2005 Dec; 15(6):708-15. PubMed ID: 16263271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated protein-ligand crystallography for structure-based drug design.
    Mooij WT; Hartshorn MJ; Tickle IJ; Sharff AJ; Verdonk ML; Jhoti H
    ChemMedChem; 2006 Aug; 1(8):827-38. PubMed ID: 16902937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learnt from structural studies of the oestrogen receptor.
    Pike AC
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):1-14. PubMed ID: 16522516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear hormone receptor targeted virtual screening.
    Schapira M; Abagyan R; Totrov M
    J Med Chem; 2003 Jul; 46(14):3045-59. PubMed ID: 12825943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of protein-ligand complexes.
    Hassell AM; An G; Bledsoe RK; Bynum JM; Carter HL; Deng SJ; Gampe RT; Grisard TE; Madauss KP; Nolte RT; Rocque WJ; Wang L; Weaver KL; Williams SP; Wisely GB; Xu R; Shewchuk LM
    Acta Crystallogr D Biol Crystallogr; 2007 Jan; 63(Pt 1):72-9. PubMed ID: 17164529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life in the fast lane for protein crystallization and X-ray crystallography.
    Pusey ML; Liu ZJ; Tempel W; Praissman J; Lin D; Wang BC; Gavira JA; Ng JD
    Prog Biophys Mol Biol; 2005 Jul; 88(3):359-86. PubMed ID: 15652250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
    Zhou HB; Sheng S; Compton DR; Kim Y; Joachimiak A; Sharma S; Carlson KE; Katzenellenbogen BS; Nettles KW; Greene GL; Katzenellenbogen JA
    J Med Chem; 2007 Jan; 50(2):399-403. PubMed ID: 17228884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain.
    Möcklinghoff S; Rose R; Carraz M; Visser A; Ottmann C; Brunsveld L
    Chembiochem; 2010 Nov; 11(16):2251-4. PubMed ID: 20922740
    [No Abstract]   [Full Text] [Related]  

  • 14. Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials.
    Hoppe C; Steinbeck C; Wohlfahrt G
    J Mol Graph Model; 2006 Mar; 24(5):328-40. PubMed ID: 16260161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization by capillary counter-diffusion and structure determination of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with a high-affinity peptide ligand.
    Cámara-Artigas A; Palencia A; Martínez JC; Luque I; Gavira JA; García-Ruiz JM
    Acta Crystallogr D Biol Crystallogr; 2007 May; 63(Pt 5):646-52. PubMed ID: 17452790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-crystallization treatments for improving diffraction quality of protein crystals.
    Heras B; Martin JL
    Acta Crystallogr D Biol Crystallogr; 2005 Sep; 61(Pt 9):1173-80. PubMed ID: 16131749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ X-ray analysis of protein crystals in low-birefringent and X-ray transmissive plastic microchannels.
    Ng JD; Clark PJ; Stevens RC; Kuhn P
    Acta Crystallogr D Biol Crystallogr; 2008 Feb; 64(Pt 2):189-97. PubMed ID: 18219119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-plate protein crystallization, in situ ligand soaking and X-ray diffraction.
    le Maire A; Gelin M; Pochet S; Hoh F; Pirocchi M; Guichou JF; Ferrer JL; Labesse G
    Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):747-55. PubMed ID: 21904027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods.
    Manas ES; Xu ZB; Unwalla RJ; Somers WS
    Structure; 2004 Dec; 12(12):2197-207. PubMed ID: 15576033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.
    Chao EY; Collins JL; Gaillard S; Miller AB; Wang L; Orband-Miller LA; Nolte RT; McDonnell DP; Willson TM; Zuercher WJ
    Bioorg Med Chem Lett; 2006 Feb; 16(4):821-4. PubMed ID: 16307879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.